A culture-independent nucleic acid diagnostics method for use in the detection and quantification of Burkholderia cepacia complex contamination in aqueous finished pharmaceutical products. [PDF]
Duong H +4 more
europepmc +1 more source
Evaluation of antimicrobial susceptibility testing methods for Burkholderia cepacia complex isolates from people with and without cystic fibrosis. [PDF]
Jorth P +15 more
europepmc +1 more source
Cloaking antibodies are prevalent in <i>Burkholderia cepacia</i> complex infection and their removal restores serum killing. [PDF]
Pham A +7 more
europepmc +1 more source
Burkholderia cepacia complex in cystic fibrosis: critical gaps in diagnosis and therapy. [PDF]
Gutiérrez Santana JC +1 more
europepmc +1 more source
A CRISPR-Cas-associated transposon system for genome editing in Burkholderia cepacia complex species. [PDF]
Yap ZL +4 more
europepmc +1 more source
Bismuth drug eradicates multi-drug resistant <i>Burkholderia cepacia</i> complex <i>via</i> aerobic respiration. [PDF]
Li J +7 more
europepmc +1 more source
First case of New Delhi metallo β-lactamase-1 (NDM-1)-producing Burkholderia cepacia complex in Iran. [PDF]
Adariani AR +5 more
europepmc +1 more source
Taxonomy and pathogenesis of the Burkholderia cepacia complex
Patients with cystic fibrosis (CF) are susceptible to chronic respiratory infection with a number of bacterial pathogens. The Burkholderia cepacia complex bacteria are problematic CF pathogens because (i) they are very resistant to antibiotics, making respiratory infection difficult to treat and eradicate; (ii) infection with these bacteria is ...
Eshwar Mahenthiralingam +1 more
exaly +4 more sources
Social Interactions in the Burkholderia Cepacia Complex: Biofilms and Quorum Sensing
Burkholderia cepacia complex bacteria are opportunistic pathogens that cause respiratory tract infections in susceptible patients, mainly people with cystic fibrosis. There is convincing evidence that B.
Tom Coenye
exaly +3 more sources

